European Space Agency   Report issue

Academic/Hospital Phase 1
Founded: Paris France (1975)

Organization Overview

First Clinical Trial
2001
NCT00311571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

European Space Agency

Active Ingredients

Drugs in Phase 1 Trials (1)

etidronic acid (1 trial)

Drugs in Other Trials (6)

bicarbonate (1 trial)

bifidobacterium longum (1 trial)

maltodextrin (1 trial)

sodium bicarbonate (1 trial)

stearic acid (1 trial)

whey protein (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 7